Ethnic inequalities in routes to diagnosis of cancer: a population-based UK cohort study

Author:

Martins TanimolaORCID,Abel Gary,Ukoumunne Obioha C.,Mounce Luke T. A.,Price SarahORCID,Lyratzopoulos GeorgiosORCID,Chinegwundoh Frank,Hamilton William

Abstract

Abstract Background UK Asian and Black ethnic groups have poorer outcomes for some cancers and are less likely to report a positive care experience than their White counterparts. This study investigated ethnic differences in the route to diagnosis (RTD) to identify areas in patients' cancer journeys where inequalities lie, and targeted intervention might have optimum impact. Methods We analysed data of 243,825 patients with 10 cancers (2006–2016) from the RTD project linked to primary care data. Crude and adjusted proportions of patients diagnosed via six routes (emergency, elective GP referral, two-week wait (2WW), screen-detected, hospital, and Other routes) were calculated by ethnicity. Adjusted odds ratios (including two-way interactions between cancer and age, sex, IMD, and ethnicity) determined cancer-specific differences in RTD by ethnicity. Results Across the 10 cancers studied, most patients were diagnosed via 2WW (36.4%), elective GP referral (23.2%), emergency (18.2%), hospital routes (10.3%), and screening (8.61%). Patients of Other ethnic group had the highest proportion of diagnosis via the emergency route, followed by White patients. Asian and Black group were more likely to be GP-referred, with the Black and Mixed groups also more likely to follow the 2WW route. However, there were notable cancer-specific differences in the RTD by ethnicity. Conclusion Our findings suggest that, where inequalities exist, the adverse cancer outcomes among Asian and Black patients are unlikely to be arising solely from a poorer diagnostic process.

Funder

Cancer Research UK

DH | National Institute for Health Research

National Institute for Health Research Applied Research Collaboration South West Peninsula

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Reference53 articles.

1. Howlader NNA, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, et al. SEER Cancer Statistics Review, 1975-2018. 2021. https://seer.cancer.gov/csr/1975_2018/. Accessed 01 Jun 2021.

2. National Cancer Intelligence Network. Cancer Incidence and Survival by Major Ethnic Group, England,2002-2006. 2009. http://www.ncin.org.uk/search/cancer+incidence+and+survival+by+major+ethnic+group. Accessed 01 Jun 2021.

3. Jack RH, Davies EA, Moller H. Breast cancer incidence, stage, treatment and survival in ethnic groups in South East England. Br J Cancer. 2009;100:545–50.

4. Metcalfe C, Evans S, Ibrahim F, Patel B, Anson K, Chinegwundoh F, et al. Pathways to diagnosis for Black men and White men found to have prostate cancer: the PROCESS cohort study. Br J Cancer. 2008;99:1040–5.

5. Cancer Research UK. Cancer mortality for all cancers combined. 2019. https://www.cancerresearchuk.org/health-professional/cancer-statistics/mortality/all-cancers-combined Accessed 01 Jun 2021.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3